IP Library Granted Patent US 12673127
Granted Patent B2
US 12673127 · App. 17/756,234 · Granted Jul 7, 2026

Liquid embolic material composition

Inventors: Ichiro Yuki (Irvine, CA); Shuichi Suzuki (Irvine, CA); Kousaku Ohkawa (Irvine, CA); Frank P.K. Hsu (Irvine, CA)
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
A61L24/001A61L24/043A61L24/08A61L2300/214A61L2300/232A61L2400/06A61L2430/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12673127
App. No.
17/756,234
Granted
Jul 7, 2026
Kind
B2
Abstract

A liquid embolic composition of natural polymers, water, and angiographic contrast agents improves neurovascular interventions, making them more reliable, safe, and affordable. The embolic material is made of a single component activated by blood calcium ion, which triggers coagulation, and that offers superior mechanical stability and does not cause fragmentation in the target vessel. The material retains superior long-term mechanical durability after deployment and provides sufficient visualization under fluoroscopy with iodine-based angiographic contrast compounds or other radiopaque compositions. Described herein are aqueous solutions that enable a high concentration gellan gum (greater than 0.5 wt %) to retain sol state even at the range of body temperature (30-40° C.). This discovery means that it is possible to increase the concentration of gellan gum without losing its inject-ability, yet significantly improve its mechanical stability after delivery.

Claims (29)

1 . A composition comprising:

(a) 0.8-2.0 wt % gellan gum;

(b) 0.01-20 wt % low molecular weight polyols and/or amino acids, wherein the low molecular weight polyols have a molecular mass less than 1000 Daltons; and

(c) 10-40 wt % radiopaque material.

2 . The composition of claim 1 , wherein the gellan gum of (a) is 0.8-1.0 wt %.

3 . The composition of claim 1 , wherein the low molecular weight polyols and/or amino acids of (b) is 3-10 wt %.

4 . The composition of claim 1 , wherein the composition retains a sol state upon annealing to 30-40° C.

5 . The composition of claim 1 , which is free of alginate.

6 . The composition of claim 1 , further comprising alginate.

7 . The composition of claim 1 , wherein the low molecular weight polyols are selected from the group consisting of: glucose, mannose, glucitol, mannitol, ribose, arabinose, and xylose.

8 . The composition of claim 1 , wherein the low molecular weight amino acids are selected from the group consisting of: glycine, alanine, valine, leucine, β-alanine, sarcosine, glutamate, aspartate, pyroglutamate, proline, serine, betaine, hydroxyproline, and threonine.

9 . A method of preparing a liquid embolic composition, the method comprising combining, at 80-90° C.:

(a) 0.8-2.0 wt % gellan gum solution,

(b) 0.01-20 wt % low molecular weight polyols and/or amino acids; and

(c) 10-40 wt % radiopaque material,

wherein the low molecular weight polyols have a molecular mass less than 1000 Daltons.

10 . The method of claim 9 , wherein the gellan gum of (a) is 0.8-1.0 wt %.

11 . The method of claim 9 , wherein the low molecular weight polyols and/or amino acids of (b) is 3-10 wt %.

12 . A method of embolizing a target blood vessel in a subject, the method comprising:

(a) introducing a catheter into the target blood vessel; and

(b) injecting a composition of claim 1 into the target blood vessel via the catheter.

13 . The method of claim 12 , wherein step (b) is performed under fluoroscopy.

14 . The method of claim 12 , wherein step (b) is performed until complete occlusion of the target blood vessel is confirmed.

15 . The method of claim 12 , wherein the target blood vessel is a cerebral artery.

16 . A composition consisting of:

(a) 0.8-2.0 wt % gellan gum;

(b) 0.01-20 wt % low molecular weight polyols and/or amino acids; and

(c) 10-40 wt % radiopaque material,

wherein the low molecular weight polyols have a molecular mass less than 1000 Daltons.